Navigation Links
Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago
Date:11/27/2009

SALT LAKE CITY, Nov. 27 /PRNewswire-FirstCall/ -- Booth - 3646/South Hall A - Varian Medical Systems, Inc. (NYSE: VAR), a premier supplier of X-ray tubes and flat panel digital image detectors, will exhibit its full range of detectors at the RSNA Annual Meeting in Chicago, Ill. from November 29 - December 3, 2009. Varian will also be exhibiting X-ray tube technology for multiple modalities as well as specialized cancer treatment technologies.

Varian's exhibit will showcase the latest X-ray technology including:

  • A broad array of X-ray tubes with applications for CT scanners, radiographic/fluoroscopic imaging, special procedures and mammography.
  • PaxScan dynamic X-ray detectors designed for use in cardiology, angiography, cone-beam CT, surgical C-arms, and image-guided radiation therapy (IGRT).
  • PaxScan radiographic X-ray detectors intended for use in capturing large fields of view, with applications in radiographic tables, wall stands, and mobile imaging systems.

"We've expanded our PaxScan portfolio and added a 43cm x 36cm hand-held portable radiographic panel with enhanced features," said Steve Kimmel, Vice President X-Ray Products Marketing. "The new panel reflects our continued commitment to build comprehensive digital imaging products in response to the medical community's requirements for improved workflow and productivity."

Varian will also exhibit new technology enhancements designed to make radiotherapy and radiosurgery treatments faster, more accurate, and easier to plan and deliver. The company's solutions for radiotherapy treatment planning, image guidance, treatment delivery, and information and patient record management will all be on display. This exhibit will include RapidArc® technology, which is now in use at over 270 cancer treatment centers worldwide for delivering radiotherapy and radiosurgery, to treat lung, liver, kidney, spine, and brain cancer more quickly and precisely than was possible with earlier technologies.

About Varian Medical Systems

Varian X-Ray Products is a premier supplier of X-ray tubes and digital detectors for X-ray imaging in medical, dental, veterinary, scientific, and industrial applications. X-Ray Products is a business unit of Varian Medical Systems, Inc., of Palo Alto, California. Varian is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. The company also supplies X-ray imaging products for cargo screening and industrial non-destructive inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, China and Europe and in its 79 sales and support offices around the world. For more information, visit http://www.varian.com/.


FOR INFORMATION CONTACT:
Elaine Fairless, Varian Medical Systems
801-978-5715   elaine.fairless@varian.com

SOURCE Varian Medical Systems, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems to Showcase the Latest X-Ray Image Detectors and X-Ray Tubes at the MEDICA 2009 International Trade Fair
2. Varian, Inc. Reports Fourth Quarter 2009 Results
3. Varian, Inc. to Release Fourth Quarter and Full Fiscal Year 2009 Financial Results
4. Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal
5. Varian Medical Systems to Exhibit a Wide Selection of Flat Panel X-Ray Image Detectors and X-Ray Tubes at the CMEF Show in Chengdu, China
6. Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES
7. Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects
8. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
9. Pivotal Registration Trial of OPAXIO Maintenance Therapy in First-Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients, Cell Therapeutics and the Gynecologic Oncology Group Discuss Potential for Early Interim Analysis
10. FDA Clears a Test for Ovarian Cancer
11. Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... Dec. 8, 2016 Allergy Diagnostics Market: ... and tests that are used to determine the ... milk, or drugs etc. in the samples by ... immune system. The report on global allergy diagnostics ... the market. The report consists of an executive ...
(Date:12/8/2016)... Research and Markets has announced the addition of the "Endodontic ... ... analyzes the worldwide markets for Endodontic Supplies in US$ Thousand. The report provides ... Japan , Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2015 through 2022. Also, a ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... December 10, 2016 , ... ... Santa are all sources of external stimuli that can put a great deal ... pressure to spread holiday cheer through gifts, food and festive gatherings can lead ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... counseling and aural rehabilitation—provided by audiologists—to remain a critical part of public access ... and Drug Administration (FDA) announced this week that, starting immediately, it ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Justin Veatch Fund ... (NCADD) is recommending the film Whispering Spirits and its discussion guide ... Columbia as an education tool in the war against teen drug abuse. NCADD ...
(Date:12/9/2016)... ... 09, 2016 , ... MEDI+SIGN®, a provider of fully-automated patient ... solution for Emergency Departments (ED) has been added to their portfolio. Housed in ... rooms, and with a simplified pallet of information available to the patient, the ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking attendance at ... for its 33rd Annual Issues & Research Conference, March 2-3, 2017, at ... the conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the ...
Breaking Medicine News(10 mins):